Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
TCRX compared with PASG: revenue, margins and what each company keeps, and the suppliers and customers both name
TCRX
TScan Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
PASG
Passage BIO, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
TCRX
TScan Therapeutics, Inc.
vs
PASG
Passage BIO, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Supply-chain overlap
Desk
News
Calendar
Saved
Search
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only TCRX
4
AMGN
Amgen
customer
NVS
Novartis
customer
—
Brigham and Women's Hospital, Inc. (BWH)
unlisted
supplier
—
Phsa
unlisted
supplier
Shared
0
No shared counterparties.
Only PASG
1
—
Gemma
unlisted
supplier
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
TCRX
TScan Therapeutics, Inc.
Change
0.19
▲
+5.86%
Mkt cap
$12.1M
Revenue
$1M
Q2 FY26
Revenue
$10M
FY25
PASG
Passage BIO, Inc.
Change
3.44
▲
+3.61%
Regular session
Nov 3 '26
Mkt cap
$10.7M
Revenue
$99,000
Q3 FY24
Revenue
—
vs
Compare
Regular session
Nov 3 '26
TCRX
TScan Therapeutics, Inc.
vs
PASG
Passage BIO, Inc.
0.19
▲
+5.86%
Price
3.44
▲
+3.61%
$12.1M
Mkt cap
$10.7M
Q2 FY26
$1M
Revenue
$99,000
Q3 FY24
FY25
$10M
Revenue
—
Change
Change
TCRX
0.19
▲
+5.86%
vs
PASG
3.44
▲
+3.61%
Regular session
Nov 3 '26